Study guide

7.4 Sharps Injury Prevention, Product Sensitivities, & Alternatives

CBIC Associate Infection Prevention and Control a-IPC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the CBIC a-IPC Certification 1.2 Exam Format, Scoring, & Logistics 1.3 Effective Study Strategies & Preparation Plan

2 Chapter 2: Processes to Identify Infectious Diseases

2.1 Chain of Infection & Pathogen Characteristics 2.2 Diagnostic & Laboratory Testing in IPC 2.3 Identifying Healthcare-Associated Infection Syndromes 2.4 Specimen Collection, Handling, Storage, & Transport 2.5 Colonization, Infection, Contamination, & Pseudo-Infection 2.6 Prophylactic, Empiric, & Therapeutic Antimicrobial Use 2.7 Host Risk Factors & Emerging Infectious Disease Threats

3 Chapter 3: Surveillance and Epidemiologic Investigation

3.1 Surveillance Methods & Program Design 3.2 Epidemiological Calculations & Rate Metrics 3.3 Outbreak Investigation Protocols & Epidemic Curves 3.4 NHSN Definitions & Standardized Infection Ratios (SIR) 3.5 Descriptive Statistics & Presenting Surveillance Data 3.6 Surveillance Across the Care Continuum 3.7 Notifiable Disease Reporting, Data Sources, & Registries 3.8 Data Validation & Surveillance Program Evaluation 3.9 Outbreak Control Measures, Environmental Sampling, & Reporting

4 Chapter 4: Preventing and Controlling Transmission

4.1 Standard Precautions & Hand Hygiene Guidelines 4.2 Transmission-Based Precautions & Isolation Protocols 4.3 PPE Selection, Donning, Doffing, & Safety 4.4 Safe Injection Practices & Medication Preparation 4.5 Patient-Care Equipment & Point-of-Care Device Handling 4.6 Emergency Preparedness & the Infection Preventionist's Disaster Role 4.7 Bioterrorism, Special Pathogens, & Community Response Planning

5 Chapter 5: Environment of Care

5.1 Environmental Cleaning & Surface Disinfection 5.2 Water Utilities, Air Handling, & Building Systems 5.3 Construction, Renovation, & Infection Control Risk Assessment (ICRA) 5.4 Laundry, Linen, Waste Management, & Food Safety 5.5 Product Recalls, Supply Chain Monitoring, & Device Incident Reporting

6 Chapter 6: Cleaning, Disinfection, and Sterilization of Medical Devices

6.1 Spaulding Classification System 6.2 Reprocessing Steps & High-Level Disinfection (HLD) 6.3 Sterilization Methods, Monitoring, & Quality Assurance 6.4 Single-Use Devices, Outsourced Reprocessing, & IFU Review 6.5 Reprocessing Failure Investigation & Patient Notification

7 Chapter 7: Employee and Occupational Health

7.1 Occupational Exposures & Post-Exposure Prophylaxis 7.2 Healthcare Personnel Immunizations & Screening 7.3 Work Restrictions & Fit-for-Duty Evaluations 7.4 Sharps Injury Prevention, Product Sensitivities, & Alternatives

8 Chapter 8: Management, Communication, and Antimicrobial Stewardship

8.1 IPC Program Governance, Policies, & Accreditation 8.2 Interdisciplinary Collaboration & Crisis Communication 8.3 Antimicrobial Stewardship Principles & Interventions 8.4 Chain of Command, Resource Advocacy, & the Business Case

9 Chapter 9: Education, Research, and Performance Improvement

9.1 Adult Learning Principles & Staff Education 9.2 Quality Improvement Models & Implementation Science 9.3 Critical Appraisal of Infection Prevention Literature

7.4 Sharps Injury Prevention, Product Sensitivities, & Alternatives

Key Takeaways Explain This Topic AI

The Needlestick Safety and Prevention Act requires a Sharps Injury Log, annual review of the Exposure Control Plan with documented consideration of safer devices, and input from non-managerial frontline employees in device selection.

Engineering controls such as safety-engineered devices and needleless connectors outrank work practice controls and personal protective equipment in the hierarchy of controls.

Recapping needles is prohibited unless no alternative exists, in which case a one-handed scoop technique or a mechanical device must be used.

Type I latex allergy is an immediate IgE-mediated hypersensitivity that can be life-threatening, while Type IV is a delayed contact dermatitis caused by chemical accelerators rather than latex protein.

Glutaraldehyde and other high-level disinfectants cause occupational asthma and dermatitis, so ventilation, closed systems, and substitution with alternative chemistries are the appropriate controls.

Last updated: August 2026

7.4 Sharps Injury Prevention, Product Sensitivities, & Alternatives

Quick Answer: The Needlestick Safety and Prevention Act (2000) amended the OSHA Bloodborne Pathogens Standard to require a Sharps Injury Log , annual Exposure Control Plan review documenting evaluation of safer devices, and frontline non-managerial employee input into device selection. Engineering controls come first. Latex Type I is immediate IgE hypersensitivity; Type IV is delayed contact dermatitis from chemical accelerators.

Section 7.1 covers what happens after an exposure. This section covers preventing it, and the related blueprint task of consulting with appropriate personnel on use of alternative infection prevention options , such as product allergies.

The Regulatory Requirements

The Needlestick Safety and Prevention Act of 2000 added three concrete obligations to 29 CFR 1910.1030:

1. The Sharps Injury Log

A log maintained in a manner that protects employee confidentiality, recording at minimum:

  • The type and brand of device involved
  • The department or work area where the incident occurred
  • An explanation of how the incident occurred

This granularity is deliberate: it is what allows a facility to identify that one brand of winged steel needle causes a disproportionate share of injuries.

2. Annual Exposure Control Plan review

The plan must be reviewed and updated at least annually , and whenever new tasks or procedures affect exposure . The review must document consideration and implementation of appropriate, commercially available, effective safer devices . "We looked and there was nothing" is not sufficient once safer devices exist on the market.

3. Frontline employee input

Employers must solicit input from non-managerial employees responsible for direct patient care in identifying, evaluating, and selecting engineering and work practice controls, and must document that solicitation in the Exposure Control Plan. A safety device selected without the input of the people who will use it is routinely defeated in practice.

Controls, In Order of Effectiveness

Loading diagram...

Key work practice rules

Do not recap. If recapping is unavoidable for a specific clinical reason, use a one-handed scoop technique or a mechanical recapping device — never a two-handed recap.

Do not bend, shear, or break contaminated needles.

Activate the safety mechanism immediately after use, before setting the device down.

Neutral zone / hands-free technique in the operating room: sharps are placed in a designated basin or magnetic pad rather than passed hand to hand. This eliminates a substantial share of intraoperative injuries.

Announce sharps passes verbally.

Blunt suture needles for fascia and muscle closure substantially reduce suture-needle injuries and should be default where clinically appropriate.

Double gloving in surgery reduces the volume of blood inoculated when a puncture occurs and detects perforations; it does not prevent the puncture.

Analyzing Sharps Injury Data

The log becomes prevention only when it is analyzed. Standard cuts:

  • Dimension What it reveals
  • Device type and brand A specific device to replace
  • Department Operating rooms and patient rooms dominate; targets education and device selection

Occupation Nurses sustain the most injuries overall; surgeons and surgical technologists have the highest rates in the OR; environmental services and laundry staff are injured by improperly discarded sharps

Timing in the workflow During use, after use before disposal, or during/after disposal — the last category points squarely at container placement and overfilling

Whether a safety device was in place, and whether it was activated Distinguishes a device problem from a training problem

Benchmarking uses injuries per 100 occupied beds or per 100 full-time equivalents, drawing on tools such as EPINet .

Exam Tip: Underreporting is the dominant data problem — a large fraction of injuries are never reported, with the highest underreporting among physicians and surgical staff. A falling injury rate may reflect falling reporting. Reporting culture, an easy reporting process, and 24-hour access to evaluation are prerequisites to trusting the data.

  • Product Sensitivities and Alternatives
  • Natural rubber latex

Reaction Mechanism Presentation Management

Irritant contact dermatitis Not allergic — friction, soap residue, incomplete drying, occlusion Dry, itchy, cracked skin Correct handwashing/drying technique, moisturizers, glove liners

Type IV — allergic contact dermatitis Delayed hypersensitivity to chemical accelerators (thiurams, carbamates), not to latex protein Eczematous rash 24–48 hours after contact, extends beyond the glove line Accelerator-free gloves; latex may still be tolerated

Type I — immediate hypersensitivity IgE-mediated response to latex protein Urticaria, rhinitis, conjunctivitis, bronchospasm, anaphylaxis within minutes Complete latex avoidance ; latex-safe environment for the worker and any latex-allergic patient

Risk factors for Type I sensitization include frequent glove use, spina bifida, multiple surgeries, and cross-reactive food allergies (banana, avocado, kiwi, chestnut). Powdered latex gloves were the major sensitization route because powder aerosolizes latex protein into ambient air; FDA banned powdered patient examination and surgeon's gloves effective January 2017 . Nitrile gloves are the standard alternative and provide equivalent barrier protection.

Chemical sensitivities

Agent Occupational effect Controls

Glutaraldehyde Occupational asthma, rhinitis, contact dermatitis, eye irritation Closed reprocessing systems, dedicated local exhaust ventilation, air monitoring, substitution with ortho-phthalaldehyde (OPA) or peracetic acid

Ortho-phthalaldehyde Skin and mucous membrane staining and irritation; anaphylaxis reported in repeatedly exposed urologic patients Ventilation, thorough rinsing, PPE

Peracetic acid Respiratory and eye irritation Closed automated systems, ventilation

Quaternary ammonium compounds Occupational asthma, dermatitis Pre-saturated wipes rather than spray, ventilation, alternative chemistries

Sodium hypochlorite Respiratory irritation; hazardous with acid or ammonia mixtures Ventilation, never mix, use pre-diluted products

Chlorhexidine gluconate Rare but genuine anaphylaxis Documented alternative such as povidone-iodine for the specific individual

Alcohol-based hand rub Stinging on damaged skin — usually a sign of pre-existing dermatitis, not allergy Skin care program, emollients; do not revert to soap and water as the routine method on this basis

The infection preventionist's consultation role

When a staff member cannot tolerate a standard product, the IP is asked to identify an alternative. The judgment must satisfy three tests simultaneously:

Is the alternative effective for the required task — the same EPA claims, the same barrier standard, the same contact time?

Is it compatible with the devices and surfaces involved?

Is it available reliably , and does the affected worker know how to obtain it?

Work with occupational health, which owns the medical evaluation, and document the accommodation. The Exposure Control Plan should name the alternatives available so a worker with a sensitivity is not left improvising at 3 a.m. Never solve a sensitivity by allowing the worker to omit the control entirely — a nurse who cannot tolerate one glove material needs a different glove, not fewer gloves.